Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Life Science Startup Investors in China in January 2026

Last updated: Jan 2026 A list of 50 angel investors and VC (Venture Capital) funds that invest in Life science startups based in China. We rank investors based on the number of investments they made in Life science companies from China. We update this investor list every month.

Top 50 Life Science Startup Investors in China in January 2026

Investor	Life Science China investments
Prox Ventures	7
Qiming Venture Partners	5
HSG	5
Hillhouse Investment	5
EFung Capital	4
Huagai Capital	4
Legend Capital	3
CD Capital	3
ULTIMA	3
ZSVC	3
Vinno Capital	3
Linear Capital	3
WuXi AppTec	3
Entrepreneurship Relay Group	3
MiraclePlus	3
CITIC Capital Holdings	3
BioVenture	3
Shunwei Capital	2
Lucion	2
Rivercity Investment	2
Tsinghua Capital	2
Danen Capital	2
Gaw Capital Partners	2
CentreGold Capital	2
Innoangel Fund	2
Huimei Capital	2
BOHE Angel Fund	2
Haitang Fund	2
Lenovo Capital and Incubator Group (LCIG)	2
Jan Hammer	2
Oriental Fortune Capital	2
Northern Light Venture Capital	2
Lilly Asia Ventures	2
Starlight Capital	2
Hillhouse Ventures	2
Yida China Holdings	2
Orient Securities Capital Investment	2
Tianjin Venture Capital	2
Zoo Capital	2
Baidu Ventures	2
Shangshi Fund	2
Hillhouse Investment	2
BMC	2
K2VC	2
Matrix Partners China	2
Highlight Capital	2
Dalton Venture	2
Eight Roads Ventures	2
CDH Investments	2
Puhua Capital	2

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

Investment focus

Medical, Biotechnology, Health Care
Seed, Funding Round, Series A
China, United States, United Kingdom

Portfolio highlights

Brise Pharma — Brise Pharma operates in the scientific research and technical service industry.
Tuanxiang Pharmaceutical — Tuanxiang Pharmaceutical is an innovative drug research and development company that combines traditional new drug research and development with the use of the world's leading unique phase separation technology.
Rapafusyn Pharmaceuticals — Rapafuysn is pioneering RapaGlues - a modality of non-degrading molecular glues that addresses hard-to-drug targets.

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.

Investment focus

Health Care, Biotechnology, Medical
Series B, Series A, Series C
China, United States, Hong Kong

Portfolio highlights

Keystone — Kesytone is a hardware wallet for bitcoin, Ethereum, USDT, BCH, and cryptocurrencies.
Ronghe Medical — Ronghe Medical is a medical device manufacturer specializing in the design, research and development, production, and sales of high-end medical device systems based on advanced energy ablation technology platforms, delivering innovative therapeutic solutions that enhance clinical precision, improve patient outcomes, and support a wide range ofmedical applications.
InfStones — Founded in 2018 with offices across three countries and two continents, InfStones is the world's leading blockchain infrastructure provider. Currently, InfStones provides services to large institutional clients around the globe, supporting thousands of nodes on more than 50 public blockchains through its universal platform.

We help founders build enduring companies.

Investment focus

Health Care, Biotechnology, Artificial Intelligence
Series A, Series B, Series C
China, United States, Hong Kong

Portfolio highlights

MarqVision — Effortlessly discover and remove counterfeits to protect your sales and reputation.
Midas — Midas is the first neobroker of Turkey, providing zero commission Turkish and American stocks.
Yunzhou Zhiwei — Yunzhou Zhiwei is a high-tech startup focused on serving large-scale equipment maintenance industries such as aviation, aerospace, shipbuilding, and rail transit. It leverages smart maintenance concepts and advanced digital technologies to make complex equipment maintenance more efficient and lean. The company drives industrial transformationtoward intelligent maintenance, helping enterprises enhance growth, efficiency, and operational excellence.

Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.

Investment focus

Biotechnology, Health Care, Software
Series B, Series A, Series C
China, United States, Singapore

Portfolio highlights

Sainte — Sainte is a company which provides professional nutritional solutions for babies with different nutritional needs
Vita Dynamics — Vita Dynamics involves learning through real-world interactions by developing robots that can physically engage with their environment, they can adapt more naturally and efficiently.
Horizon Continental Technology — Horizon Continental Technology is a joint venture between Continental Group and Horizon Robotics

Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Series A, Series C, Series B
China, United States, India

Portfolio highlights

QureBio — QureBio focuses on the research and development of innovative macromolecular biopharmaceuticals. Its goal is to develop new therapeutic drugs for the treatment of refractory cancer, autoimmune diseases, and metabolic diseases in China and the world to benefit patients. QureBio has multiple technology platforms for antibody drug developmentincluding phage display technology platforms and hybridoma antibodies technology platform and monoclonal antibody platform.The company was founded in 2017 and is based in Pudong District, Shanghai.
Pleryon Therapeutics — Innovations in biofunctional polymers
Tingsheng Technology — TINGSN develops Intracardiac echocardiography (ICE) catheter imaging technology designed to treat cardiac arrhythmia. In addition to ICE products, the company has developed its own heart internal catheter positioning and software algorithms and is developing China first computer surgical simulator for cardiac electrophysiology based on digitalheart model.

Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Seed
China, United States, Germany

Portfolio highlights

ViGeneron — ViGeneron is dedicated to developing innovative gene therapies to treat ophthalmic diseases with high unmet medical need, as well as partnering with leading biopharmaceutical players in other disease areas. The company’s pipeline is built on two proprietary adeno-associated virus (AAV) technology platforms. The first, vgAAV gene therapy vectorplatform, allows superior transduction efficiency and intravitreal, less invasive treatment administration. The second, REVeRT vector platform, targets diseases caused by mutations in large genes. Privately-owned ViGeneron was founded in 2017 by a seasoned team with in-depth experience in AAV vector technology and clinical ophthalmic gene therapy programs and is located in Munich, Germany.
Moyang Biotechnology — Moyang Biotechnology specializes in the development and consulting services of medical biomaterials for beauty sector.
Index Technology — Index Technology is a company that specializes in applying artificial intelligence technology to electronic design and production. Index Technology uses generative AI technology to optimize the traditional R&D process for electrical devices, and it offers automated generation services ranging from product requirements to PCBA manufacturingdesigns and supporting embedded programs.

Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.

Investment focus

Health Care, Medical, Biotechnology
Series B, Series A, Series C
China, United States, South Korea

Portfolio highlights

Obita — Obita is a B2B financial network that offers stablecoin-driven transactions for enterprises, merchants, and fintechs.
X Square — X Square is a company focused on developing universal embodied large models for robots, aiming to create a universal brain-cerebellum system that offers comprehensive capabilities from perception to action.
Neolix — Neolix is a technologically innovative company that specializes in the production of physical and sports scenes. Neolithic Century Technology is an innovative design team. Committed to design research, industrial design, structural engineering, product customization, providing customers with creative value enhancement services. Service customersinclude Lenovo, Siemens, Midea, GE, State Grid, CSIC, Honeywell, Bank of China, Agricultural Bank, etc.

CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.

Investment focus

Health Care, Biotechnology, Medical Device
Series A, Series B, Seed
China, United States

Portfolio highlights

Healingovation — Healingovation is a med-tech company that specializes in the development and manufacturing of surgical robots, intelligent diagnosis and treatment equipment.
Greenon Biotech — Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on.
Qihe Biotech — Qihe Biotech develops novel genome editing technologies with an emphasis on making them autonomous and programmable.

ULTIMA is an investment management firm.

Investment focus

Hardware, Software, Agriculture
Angel, Series A
China

Portfolio highlights

Maimai — Maimai provides software and hardware smart care solutions for middle-to-high-end institutions, senior citizens, communities and home care.
Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.

ZSVC is a Chinese venture capital firm specialized in seed and early stage investments.

Investment focus

Manufacturing, Medical, Health Care
Series A, Seed, Series B
China, United States, India

Portfolio highlights

Micot — Micot is a new molecular entity drug developer for peptides, dedicated to the development of innovative drugs, multi- and protein-based innovative biopharmaceuticals, vaccines and biomolecular drug delivery systems and products, and for drug screening and biopharmaceutical research. The technology combines to provide users with Bio-Res-Deliv, abiological macromolecular respiratory drug delivery system, suitable for the treatment of cardiovascular diseases, metabolic diseases, liver diseases and the like.
Deruicore — Deruicore is an integrated research and development based manufacturing company.
Zhisheng Bio — Zhisheng Bio specialzies in product research and development, and market transformation of biopharmaceutical products.

Vinno Capital focuses on early-stage venture investments in ICT and healthcare-related fields.

Investment focus

Manufacturing, Semiconductor, Hardware
Series A, Seed, Series B
China, United States

Portfolio highlights

Huachen Core Light — Huachen Core Light is a semiconductor technology company that produces and manufactures optical communications and laser chips.
Beijing Ruidaen Technology Co. — Beijing Ruidaen Technology Co. is a manufacturer of target detection, radio interference, and laser electronic series.
Northern Hemisphere Technology — Northern Hemisphere Technology is a high-tech company specializing in automotive-grade one-piece molded inductors. Northern Hemisphere focuses on high-performance and high-quality products, uses technology to serve customers and the market.

Linear Capital is a Frontier Tech Fund founded in 2014 by Harry Wang, Facebook's first Chinese R&D manager. We currently manage 10 funds with AUM of more than $2 billion.

Investment focus

Software, Artificial Intelligence, Biotechnology
Seed, Angel, Series A
China, Germany, Hong Kong

Portfolio highlights

BTRY — BTRY is a spin-off of EMPA and ETH and is developing the industry's first energy-dense solid-state battery, using sophisticated semiconductor manufacturing technologies.
TARS — Zhihang Zhong is a prominent researcher in the field of artificial intelligence, particularly known for his work on integrating spatial perception and reasoning into AI systems.
NewPro — NewPro is in the process of increasing production and establishing regulations for lactoferrin raw materials, with the goal of bringing the product to market as quickly as feasible.

WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve theproductivity of advancing healthcare products through cost-effective and efficient solutions,With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,900 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated".

Investment focus

Biotechnology, Pharmaceutical, Health Care
Series A, Series B, Series C
United States, China, Israel

Portfolio highlights

D3 Bio — D3 Bio is a globally focused biotechnology company focusing on developing and registration of innovative medicines in oncology and immunology. At D3 Bio, our new medicine development approach is fundamentally differentiated. We do not just only start with science in the lab. First, we pinpoint the greatest unmet patient and market needs – whereexisting standard-of-care approaches yield unsatisfactory clinical outcomes. Then we take those insights into the lab to guide the identification of fit for purpose science and technology and define our drug development path.
ShouTi — ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.
Bioyond Tech — Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.

Entrepreneurship Relay Group manages a fund of more than 4 billion yuan, directly or indirectly.

Investment focus

Manufacturing, Software, Electronics
Series A, Funding Round, Angel
China

Portfolio highlights

Songying Technology — Songying Technology focuses on the research and development of cloud-native real-time 3D engines and graphics collaboration platforms.
Spectral Domain Technology — Spectral Domain Technology is a provider of 5G low-orbit broadband terminals, supplying operators, industrial Internet companies, satellite Internet, and government and enterprise customers with ocean communication needs.
Optical Standard Technology — Optical Standard Technology focuses on the design and manufacture of optical computing chips and optical computing boards for use in scenarios requiring large amounts of AI computing power, such as large model reasoning and training, autonomous driving, smart cities, quantitative finance, AI security.

MiraclePlus invests in and accelerates early-stage startups. MiraclePlus assists startups in developing products that are good enough to succeed in the market. MiraclePlus' acceleration program works with the founders to get each team in top shape so that they can present to thousands of investors on Demo Day.

Investment focus

Artificial Intelligence, Software, Information Technology
Seed, Angel, Pre-Seed
China, United States, Singapore

Portfolio highlights

TestSprite — AI powered fully automated end-to-end testing solutions to help enterprises launch their products faster.
Excellent Vision — Excellent Vision is a spatial intelligence company focused to transforming video creation into a 4D world model, enabling AI big models to grasp, generate, and reason about 4D space.
Gongji Technology — Gongji Technology is an idle computing power sharing platform that combines distributed computing power with leading scheduling techniques to address elastic computing power requirements.

CITIC Capital Holdings is an alternative investment management and advisory company headquartered in China.

Investment focus

Manufacturing, Health Care, E-Commerce
Series A, Series B, Series C
China, United States, Japan

Portfolio highlights

Xiaohongshu — Xiaohongshu is a lifestyle-sharing platform for users to share positive energy and good life through the sharing of text, pictures, and videos. Xiaohongshu offers an overseas shopping tip app. Xiaohongshu started its business by helping overseas travelers to draft a shopping list before they hit the roads. But with the aggregation of more UGCcontent, the service is transforming into a community for those who are passionate about fashion and shopping and want to know more about these fields even though they do not have overseas traveling plans on their schedules.
Healthy Tree — Healthy Tree is a comprehensive solution provider for self-medication devices.
Regional Fish — Regional Fish provides seed, seedlings, aquaculture methods and fisheries services.

Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Seed
China, United States, Hong Kong

Portfolio highlights

AusperBio — AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming hepatitis B treatment for a cure and advancing oligonucleotide therapeutics. Leveraging their innovative and proprietary Med-Oligo™ ASO platform with effective targeted delivery technologies, AusperBio strives to unleash the power of ASO therapeutics to treata wide range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases.
CART Medical — CART Medical Technologies, Ltd. is a high-tech company specializing in the development and application of new technologies for immune cell therapy. It has a 2,200 square meter GMP laboratory and research and development laboratory.
Zhiran Medical — Zhiran Medical is a medical technology company specializing in the precise detection and treatment of neurological disorders using high-throughput, flexible brain-computer interface technology.

Shunwei Capital is a venture capital fund that focuses on early to mid-stage investments in local internet industry. It specializes in incubation, startups, early to mid-stage, and growth capital investments. It seeks to invest in the technology, media, telecommunications, high technology, new media, games, internet finance, and rural area internetsectors. Their investors include sovereign wealth funds, fund of funds, university endowment funds, and family offices.

Investment focus

Manufacturing, Software, Internet
Series A, Series B, Series C
China, India, United States

Portfolio highlights

Darma — DARMA - Digital Healt
Realm of Illumination — Realm of Illumination is an AI smarter hardware developer that focuses on the research and development of AI smart terminal equipment and sensors to fulfill the application needs of artificial intelligence and the Internet of Things.
Shouxing Technology — AheadForm is pioneering the development of realistic humanoid robots designed to revolutionize human-robot interaction. Our current focus is on creating sophisticated humanoid robot heads that can express emotions, perceive their environment, and interact seamlessly with humans. By combining cutting-edge AI and advanced robotics, we aim to bring life to machines and transform the way humans engage with technology.

Lucion is an influential professional venture capital institute.

Investment focus

Biotechnology, Medical, Manufacturing
Series A, Series B, Seed
China

Portfolio highlights

Insyce — Inces is an innovative high-tech enterprise focusing on bio-separation technology.
Ubinexus — Ubinexus focuses on the overall design capabilities of satellite communication payloads and satellite-based comprehensive digital processing technology to meet the multi-dimensional needs of low-orbit mega-constellation construction and provide users with the world's leading communication payload system.
Uni-Sentry — Uni-Sentry offers information security testing tool chain and information security compliance testing platform for intelligent networked vehicles, vehicle information security penetration testing services, autonomous driving GNSS anti-spoofing anomaly detection solutions, National secret algorithm vehicle hardware security module HSM solution.

Ruijiang Investment is a market-oriented, professional and international fund management company focusing on equity investment funds, industrial investment funds and asset management business, with a management scale of more than 2 billion yuan.

Investment focus

Medical, Biotechnology, Electronics
Seed, Series A, Series C
China

Portfolio highlights

Tuo Rui Jing — Tuo Rui Jing is a global molecular diagnostic company with technological innovation at its core.
Ruixun Biotech — Ruixun Biotech is a Healthcare company.
Qianjue Technology — Qianjue Technology is a company that created the first full-stack application-level robot model and offers cloud-based artificial intelligence solutions to robot manufacturers.

Tsinghua Capital is an investment firm.

Investment focus

Manufacturing, Artificial Intelligence, Biotechnology
Seed, Angel, Series A
China, Australia

Portfolio highlights

PureblueAI — PureblueAI is an AI-powered digital workforce platform operator specializing in enterprise marketing scenarios.
Fang Yuanmingxin — Fang Yuanmingxin is a technology company specializing in precision machinery manufacturing, dedicated to providing high-quality mechanical components and innovative engineering solutions for a wide range of industrial applications.
Weizhen New Materials — Weizhen New Materials is a company focused on the research and development of new materials technologies, primarily focusing on the development and application of high-performance modified nylon materials and multifunctional composite materials.

Danen Ventures is an early-stage venture capital firm that focuses on high-growth fields, such as information technology and internet, renewable energy and environmental, advanced manufacturing industry, biotechnology and medical science, and healthcare.

Investment focus

B2B, Fashion, Medical
Series A, Angel, Seed
China, United States

Portfolio highlights

CartaBio — CartaBio is an authorised spatial omics technology platform. CartaBio specializes in the creation of AI-integrated solutions for the biotech industry, including scission-accelerated fluorophore exchange and the multimodal CellBERT model.
SynMetaBio — SynMetaBio is a company that develops synthetic biological materials, combining synthetic biology and material design. Their business modules include bio-based medical beauty, functional recombinant proteins, and medical aesthetic materials, including bionic bio-based leather.
Meiyou Technology — Meiyou Technology is a DNA synthesizer developer focusing on enzymatic long-fragment DNA synthesis and splicing technology. They use high-throughput synthesizers to reduce DNA synthesis costs and offer gene design services for the biotechnology industry.

Gaw Capital Partners is a positioned private equity fund management company that focuses in real estate markets in greater China and other high barrier-to-entry markets globally. Their services includes gateway real estate funds, separate account investments, venture capital, private equity investment and credit investments.

Investment focus

Real Estate, Property Management, Hospitality
Series A, Series C, Seed
China, Singapore, United States

Portfolio highlights

Blackpanda — Asia's premier digital forensics and cyber incident response firm.
SARELLY SARELLY — SARELLY SARELLY is a gender-neutral and transparent fashion brand, offering affordable luxury to the Hispanic Gen Z community.
NPX Point Avenue — NPX Point Avenue is an education technology company focused on the fast-growing K-12 private international school market and K-12 after-school training market.

Our team invests in early-stage digital health and consumer startups at CentreGold Capital.

Investment focus

Medical Device, Artificial Intelligence, Internet
Seed, Series A, Angel
United States, China, Canada

Portfolio highlights

Juix — Juix is a power bank rental service that allows people to charge their devices on the go.
Virgo — Accelerate GI clinical trials with AI for endoscopy. Use video to automate workflows, improve standard of care, and accelerate results.
WeBox — Saltalk is a virtual kitchen platform that focuses on Asian Authentic Food optimized for delivery services.

Innoangel Fund is an investment firm that invests in early stage companies.

Investment focus

Artificial Intelligence, Manufacturing, Robotics
Angel, Seed, Series A
China, Canada, Hong Kong

Portfolio highlights

PureblueAI — PureblueAI is an AI-powered digital workforce platform operator specializing in enterprise marketing scenarios.
Realm of Illumination — Realm of Illumination is an AI smarter hardware developer that focuses on the research and development of AI smart terminal equipment and sensors to fulfill the application needs of artificial intelligence and the Internet of Things.
Weizhen New Materials — Weizhen New Materials is a company focused on the research and development of new materials technologies, primarily focusing on the development and application of high-performance modified nylon materials and multifunctional composite materials.

Huimei Capital primarily seeks investment in the medical and healthcare ecosystem in a multi-dimensional and three-dimensional manner. It is committed to building a professional investment platform with international vision and local execution, helping early and growing medical and health companies to grow rapidly.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
China, United States, Japan

Portfolio highlights

Sniper Medical Technology — Sniper develops accurate and intelligent molecular diagnostic solutions. Taking the next-generation fully automatic digital PCR as a breakthrough, the company has developed a droplet generation method with global independent intellectual property rights - Vibrant Injection technology and created a new path of chip-free droplet generationtechnology. It solves the pain points of high cost and complicated operation of microfluidic technology in practical application and is expected to bring subversive innovation in the field of refined medical testing.
Xushui Internet — Xushui Internet provides image equipment monitoring, operation, and maintenance cloud services, large-scale equipment IoT management system, digital integration services for hospital-wide equipment, and remote collaborative image inspection system.
Chengdu Pukang Biotechnology Co. — Chengdu Pukang Biotechnology Co., Ltd specializes in the development, production, and supply of high-purity single molecular PEG series derivatives, polypeptide long-acting drug side chains, and their intermediates. The company focuses on serving the pharmaceutical industry with a range of chemical supplies that are crucial for drug development andmanufacturing processes. With a professional R&D team, Chengdu Pukang Biotechnology is dedicated to advancing pharmaceutical intermediates technology and providing solutions that meet the evolving needs of the healthcare sector. The company's commitment to research and development is evident in its continuous efforts to innovate and improve its product offerings to support the pharmaceutical industry.

BOHE Angel Fund is an investment Fund.

Investment focus

Health Care, Medical, Biotechnology
Angel, Series A, Seed
China

Portfolio highlights

QuarkMed — QuarkMed is a nuclear medicine clinical CRO service company.
Tyligand Bioscience — Tyligand Bioscience is a biotechnology company that focuses on the discovery and development of small molecule therapeutics to help patients with cancer and autoimmune diseases. Tyligand's pharmaceuticals are designed to target and treat tumors and autoimmune disorders, enabling healthcare professionals to prescribe more effective medicine andimprove health outcomes.
Yili Pharmaceutical — Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development.

Haitang Fund is a venture capital fund jointly established by Tianjin University alumni entrepreneurs and other alumni and entrepreneurs.

Investment focus

Manufacturing, Biotechnology, Medical
Seed, Series A, Funding Round
China

Portfolio highlights

Scan3D — Scan3D is a high-tech enterprise focusing on the research and development of new materials and intelligent equipment.
Tianhai Junkang — Tianhai Junkang is an enterprise focusing on the sales of Class II medical devices and related technical services.
Tianhesheng New Materials — Tianhesheng is a new materials technology company specializing in the development, production, and sales of boron isotope products. They plan to use their latest funding round to enhance research and development as well as expand market growth.

Lenovo Capital and Incubator Group is an accelerator and venture capital firm.

Investment focus

Manufacturing, Artificial Intelligence, Software
Series A, Series B, Seed
China, Hong Kong, United States

Portfolio highlights

DexForce — DexForce offers an AI-enabled robot with integrated 3D vision cameras, and software and hardware solutions for manufacturing robots.
Zhiran Medical — Zhiran Medical is a medical technology company specializing in the precise detection and treatment of neurological disorders using high-throughput, flexible brain-computer interface technology.
West Lake Yanshan Technology — West Lake Yanshan Technology is a micro-LED company that focuses on the manufacturing and production of full-color display chips.

Jan Hammer is the partner at Index and the Board observer of Harmonic. Jan attended Oxford University.

Investment focus

Health Care, Medical, Medical Device
Series A, Series B, Seed
China, United States, Czech Republic

Portfolio highlights

Sofía — Improving the way millions of people take care of their health
Transak — Transak offers a simple integration to allow your users to buy more than 100+ cryptocurrencies with credit/debit cards, or bank transfers in more than 120+ countries.
Yuetong Eye Clinic — Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.

Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.

Investment focus

Manufacturing, Software, Information Technology
Series A, Series B, Seed
China, United States

Portfolio highlights

Soundbridge AI — Soundbridge AI specializes in developing cutting-edge, AI-powered speech rehabilitation solutions designed to assist individuals with speech impairments in improving communication skills through personalized, adaptive therapy.
Xuanchuang Robotics — Xuanchuang Robotics is a leading provider of cutting-edge intelligent operations and maintenance solutions, specializing in advanced robotics technologies.
West Lake Intelligent Vision — West Lake Intelligent Vision is a developer of artificial intelligence and computational imaging fusion technology.

Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Seed
China, United States, South Korea

Portfolio highlights

iRegene — iRegene researches and develops pharmaceutical therapy for neurodegenerative and rare diseases.
Wala English — Wala English is a provider of comprehensive full-process AI contextual learning services, leveraging artificial intelligence to deliver personalized, immersive language learning experiences that adapt to each learner’s needs, context, and progress throughout their educational journey.
Hertz Life Science Technology — Hertz Life Science Technology uses virus-like particle VLPs technology to develop animal and human vaccines.The company has several underlying core patented technologies and has established a stable and efficient research and development platform based on the Jiyin Biomedical Transformation (Greater Bay Area) base, and actively promotes theresearch and development of vaccines.At present, the company has carried out extensive and in-depth cooperation with large enterprises such as Qingdao Yibang and Wen's Group, and its R&D strength has been highly recognized by peers and upstream and downstream enterprises.

Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
China, United States, Hong Kong

Portfolio highlights

Enchannel — Enchannel Medical is a global innovation platform that focuses on electrophysiology and provides atrial fibrillation treatment solution around "3D mapping + PFA ablation".
Kriya Therapeutics — Kriya is a biopharmaceutical company developing gene therapy to address common diseases that impact millions of people worldwide. Learn more.
LYNK Pharmaceuticals — LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines to treat oncology, immunology, and inflammatory diseases. The company was founded in 2018 and is headquartered in Hangzhou, Zhejiang, China.

Starlight Capital provides investment and assistance to companies from the digital industry. It searches for businesses that are focusing on digital transformation and helps with its management. Starlight Capital is based in Shanghai, China.

Investment focus

Manufacturing, Robotics, Software
Series A, Series C, Series B
China

Portfolio highlights

Hailan Acoustics — Hailan Acoustics focuses on the research and development, production and sales of marine sensors and equipment.
Wanxun Technology — Wanxun Technology is a service robot developer dedicated to flexible, dexterous and interactive service robots for industries and families.
Kedian Intelligent Cloud — Kedian Intelligent Cloud is an innovative enterprise focusing on the field of industrial hemp.

Hillhouse Venture Capital is an investment institution established by Hillhouse Capital that focuses on investing in early-stage startups.

Investment focus

Manufacturing, Biotechnology, Health Care
Series A, Series B, Seed
China, Singapore, Norway

Portfolio highlights

RoboticPlus.AI — RoboticPlus.AI is an robtics company that helps in architectural tech by providing intelligent robotic products for the construction sector.
HEMO BIOENGINEERING — HEMO BIOENGINEERING develops and provides innovative interventional medical devices to patients.
Hecheng New Materials Technology — Hecheng New Materials Technology is a manufacturing company offering bearing electrical corrosion and electrical insulation solutions.

Yida China Holdings provides park development, park operation, construction, property management, landscaping, and decoration services. Their customers inquiries are addressed through phone, email, and online applications.

Investment focus

Manufacturing, Semiconductor, Biotechnology
Series A, Series B, Funding Round
China, United States

Portfolio highlights

Sizone Technology — Sizone Technology is a chemical mechanical planarization (CMP) equipment company providing services to the semiconductor industry.
Alit Life Sciences — Alit positioned as a supplier of instruments, equipment and technical services in the life science and biotechnology industries, the company has developed several series of products from Biotech, Altair, Rigel and Mira after launching its self-developed Countstar IC1000 cell analyzer in 2011.
General Biosystems — General Biosystems is a biotechnology company that focuses on high-quality, high-throughput, automated production of DNA constructs. The company through its passion in understanding how genetic information is stored and programmed in the DNA develops innovative technologies and instruments to program and physically write or print new genetic codes.The new codes will create blueprints for new or enhanced biological and biological functions.

Orient Securities Capital Investment is an private equity fund business platform.

Investment focus

Manufacturing, Health Care, Medical
Series A, Funding Round, Series B
China

Portfolio highlights

News Dart — News Dart is a manufacturer of precision planetary reducers and helps promote automation and intelligence transmission solutions.
Picea Motion — Picea Motion is a precision harmonic drive company that specializes in the development and production of harmonic speed reducers.
Xinhui Lianxin — Xinhui Lianxin is an electronic component manufacturer, mainly engaged in the manufacturing of special equipment for semiconductor devices, semiconductor discrete devices, power electronic components, integrated circuit manufacturing, integrated circuit chips and product manufacturing.

Tianjin Venture Capital is an investment firm.

Investment focus

Manufacturing, Information Technology, Health Care
Funding Round, Seed, Series A
China, United States

Portfolio highlights

Mech-Mind Robotics — Mech-Mind is dedicated to giving intelligence to industrial robots. Through core technologies such as machine vision (2D/3D), advanced programming models, fast environment awareness, intelligent decision making, and autonomous path planning, robots will no longer be a clumsy machine that can only repeat actions, but become available toeveryone and available everywhere. Smart helper. The company's core products are high-performance 3D cameras, visual AI algorithms and software, robot motion algorithms and software, and can provide reference designs and field services for a variety of typical applications. Mecamand's complete solution enables robot manufacturers and integrators to quickly upgrade their artificial intelligence capabilities to perform applications such as disordered object capture, visual guided unraveling, mixed palletizing, and precision positioning assembly.
Xingneng Xuanguang — Xingneng Xuanguang is a fusion energy company that specializes in the development of advanced field reverse magnetic mirror fusion path technology.
Innovec Biotherapeutics — Innovec Biotherapeutics Specialized in gene therapy technology and medication development.

Zoo Capital is focusing on early-stage investments in technology, healthcare, and consumer companies.

Investment focus

Artificial Intelligence, Software, Biotechnology
Seed, Series A, Series B
China, Hong Kong, United States

Portfolio highlights

TabbyML — Tabby is an open-source AI coding assistant that empowers developers to code faster and smarter. Discover a self-contained alternative to GitHub Copilot, tailored for your development needs.
Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
Xingan Technology — Xingan Technology is a developer of SiC power semiconductor products.

Doma Protocol is a purpose-built blockchain to modernize and unlock the liquidity of over 362M existing and future domains

Investment focus

Artificial Intelligence, Health Care, Biotechnology
Series A, Seed, Series B
China, United States, Singapore

Portfolio highlights

InsForge — InsForge is the backend built for AI-assisted development. Connect InsForge with any agent. Add authentication, database, storage, functions, and AI integrations to your app in seconds.
Fastlane — We take innovative brands global. Fastlane is a full-service D2C solutions provider that assists enterprises with brand development, business infrastructure, and sales creation/growth in European, North American and Asian markets. We offer a superior one-stop solution, with expertise in go-to-market strategy, traditional and digital marketing,PR, logistics, e-commerce, sales, and platform development. We work with companies big and small, and our custom-tailored solutions range in scope from basic consulting services to 360° turnkey operations.
Zhongke Jiahe — Zhongke Jiahe develops compilation technology and aspires to build a universal, low-cost, high-performance fundamental software tool chain.

Shangshi Fund is an investment firm.

Investment focus

Information Technology, Hardware, Electronics
Series A, Angel, Series B
China

Portfolio highlights

HurRain NanoTech — HurRain NanoTech is a new functional nanomaterials service provider for atmospheric water generation solutions. It developed a platform for material screening and amplification with functional composite moisture-absorbing interfacial thermal materials as the primary R&D direction, created a product line of atmospheric water generator devicesand interfacial thermal materials, and provided customers with standardized products and solutions.
Wutong Sensing Control — Wutong Sensing Control is a leading company that specializes in the research, development, and innovation of cutting-edge robotic mechanics and tactile sensing technologies. With a strong focus on advancing automation systems, the company aims to enhance the precision, efficiency, and adaptability of robotic applications in various industries,including manufacturing, healthcare, and consumer electronics.
Silicon Ceramics New Energy — Silicon Ceramics New Energy is a manufactures synthetic quartz sand and silicon carbide, and offers chip thermal management solutions.

Investment focus

Manufacturing, Biotechnology, Software
Series A, Series B, Series C
China, United States, Singapore

Portfolio highlights

CarDekho — Thinking of buying a car? At CarDekho.com, buy new and used cars, search by filter and preferences, compare cars, read latest news and updates, see 360 views & more!
Pulse — Pulse is a health care service provider that assess coronary physiology and biomechanics through innovative techniques.
Paper Boat — Paper Boat healthy and tasty nuts and trail mixes delivered at your doorstep. Our ingredients are prepared individually - our nuts are slow-roasted to preserve its original flavour & maintain crunchiness, our berries are tossed in beautiful aromatic spices, and then combined to bring the perfect balance of flavours.

BMC engaged in asset management, investment management and consulting.

Investment focus

CAD, Medical, Computer
Seed, Series B
China

Portfolio highlights

Bochuang Biotechnology — Bochuang Biotechnology is a cutting-edge medical repair product developer that specializes in the controllable electrochemical assembly of biomacromolecules. Bochuang Biotechnology is creating a line of high-end biological tissue functional membranes and derived medical device solutions.
Jingyao Xinhui Semiconductor — Jingyao Xinhui Semiconductor is the indium phosphide optical chip manufacturer company.
Suzhou Pelotin Biotechnology — Suzhou Pelotin Biotechnology is a research firm specializing in peptides, recombinant proteins, GE antibodies, and protein expression.

K2VC (Xianfeng Evergreen) was founded in 2010, focused on early stage investment in technology start-ups in China, focus on promoting change and technological progress, innovative business models and lifestyles.

Investment focus

E-Commerce, Manufacturing, Biotechnology
Series A, Seed, Angel
China, United States, Japan

Portfolio highlights

YolTech Therapeutics — Yaotang (Shanghai) Biotechnology is a high-tech biotechnology company focusing on developing a new generation of mRNA drugs and gene editing drugs by combining mRNA in vivo delivery technology and gene editing technology. Through the continuous development and optimization of CRISPR, base editing and other new-generation gene editing tools, andinnovative improvements to the next-generation mRNA production platform and lipid nanocarrier assembly process, Yaotang Bio is committed to developing treatments for genetic diseases and cardiovascular disease.
Hangmo Technology — Hangmo Technology is a developer of advanced flexible robotics technology, primarily focused on the design and engineering of highly integrated robotic systems. The company specializes in creating compact, adaptable, and intelligent robotic solutions that can be applied across various industries, including manufacturing, healthcare, and serviceautomation
Cornerstone Robotics — Cornerstone Robotics operates to improve the accessibility of high-end medical services in China.

Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant, industry-leading companies.Since its inception in 1977, Matrix Partners China has made hundreds of investments and played an active role in the development of many successful businesses, 50 of which went on to IPO, and 75 of which have goneon to profitable M&A events. The firm consistently ranks in the top venture firms in terms of returns to its investors.Matrix Partners China combines local knowledge with global experience and vision. Its team consists of both former entrepreneurs and experienced investors. Its past successes include Focus Media, Eachnet, and Baidu, among others. The company invests across multiple sectors and stages.

Investment focus

Health Care, Biotechnology, Software
Series A, Series B, Series C
China, United States, Hong Kong

Portfolio highlights

Levostar — Levostar Biotech_Innovative Solutions for Innovative Therapies Levostar Biotech is a technology-driven enterprise focused on innovative technologies for Advanced Therapy Medicinal Products.
RoboParty — RoboParty is a bipedal robot technology company that specializes in research, development, and engineering of humanoid robots.
Ucello Therapeutics — Ucello Therapeutics is engaged in development of allogeneic cell therapies using its proprietary CAR-T cell technology platform CBT-X20.

Highlight Capital is an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Seed
China, United States, Portugal

Portfolio highlights

VelaVigo — VelaVigo is a start-up company engaged in macromolecular biopharmaceuticals.
Realm of Illumination — Realm of Illumination is an AI smarter hardware developer that focuses on the research and development of AI smart terminal equipment and sensors to fulfill the application needs of artificial intelligence and the Internet of Things.
E-nitiate Biopharmaceuticals — E-nitiate Biopharmaceuticals is committed to the development of innovative drugs for autoimmune diseases, through independent research and development, and strategic collaborations, to address unmet medical needs and to improve the quality of human life.

Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health.

Investment focus

Health Care, Medical, Medical Device
Seed, Series A, Series B
India, China, Canada

Portfolio highlights

Astribot — Astribot is a developer of consumer humanoid robots and integrated bionic robots.
Yuantian Bio — Yuantian Bio is a biotechnology company specializing in enzymatic regeneration and commercial plastic PET applications. They have achieved low-cost fermentation preparation of over 10 enzyme preparations and large-scale biochemical product preparation.
Yuetong Eye Clinic — Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.

Eight Roads has a 50+ year history of investing and partners with game-changing technology and healthcare companies, supporting them as they scale to become global leaders.

Investment focus

Software, Health Care, Information Technology
Series B, Series A, Series C
United States, China, India

Portfolio highlights

Amenitiz — The all-in-one hotel management platform for independent hotels. Streamline operations, maximize occupancy, and control your business.
StashAway — StashAway is a MAS-licensed investment platform in Singapore that's designed for portfolio and wealth management for all at low fees.
ABK Biomedical — At ABK biomedical, we are focused on developing novel Y90 radioembolization treatment options for patients with hypervascular liver tumors

CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for manyyears focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China.

Investment focus

Manufacturing, Health Care, Biotechnology
Series A, Series B, Series C
China, United States, Canada

Portfolio highlights

TMiRob — TMiRob is a medical robot developer that works with hospitals and clinics to develop medical robots to improve the work efficiency of medical workers. The medical robots developed by TMiRob can be used in medical treatment assistance and nursing services in hospitals and clinics.
SenseTime — SenseTime is a leading AI software company focused on creating a better AI-empowered future through innovation. Upholding a vision of advancing the interconnection of physical and digital worlds with AI, driving sustainable productivity growth and seamless interactive experiences, SenseTime is committed to advancing AI research, developing scalableand affordable AI software platforms that benefit businesses, people, and society, as well as attract and nurture top talents to shape the future together.With their roots in the academic world, we invest in original and cutting-edge research that allows them to offer and continuously improve industry-leading, full-stack AI capabilities, covering key fields across perception intelligence, decision intelligence, AI-enabled content generation, and AI-enabled content enhancement, as well as key capabilities in AI chips, sensors and computing infrastructure. Their proprietary AI infrastructure, SenseCore, allows us to develop powerful and efficient AI software platforms that are scalable and adaptable for a wide range of applications. Their technologies are trusted by customers and partners in many industry verticals including Smart Business, Smart City, Smart Life, and Smart Auto.SenseTime has been actively involved in the development of national and international industry standards on data security, privacy protection, ethical and sustainable AI. As of June 30, 2021, SenseTime has participated in the formulation of over 80 national or international industry standards, working closely with multiple domestic and multilateral institutions on ethical and sustainable AI development. SenseTime was the only AI company in Asia to have its Code of Ethics for AI Sustainable Development selected by the United Nations as one of the key publication references in the United Nations Resource Guide on AI Strategies published in June 2021.They have offices in markets including Hong Kong, Mainland China, Macau, Taiwan, Japan, Malaysia, Singapore, South Korea, Saudi Arabia, and the United Arab Emirates, among others, as well as a presence in Thailand, Indonesia, and the Philippines.
Spear Bio — Successive Proximity Extension Amplification Reaction (SPEAR) technology from Spear Bio enables ultra-sensitive biomarker detection using ultra-small samples.

Puhua Capital is an equity investment firm that focuses on early and middle project. Puhua Capital provides the required resources and management experience for the invested enterprise, investing funds and more resources and wisdom. Puhua Capital has invested nearly 300 excellent start-ups.

Investment focus

Health Care, Medical, Manufacturing
Series A, Series B, Seed
China, United Kingdom, United States

Portfolio highlights

Anten — Anten is a high-tech enterprise dedicated to the research, development, and production of innovative dietary supplements and precision nutrition technologies, aiming to promote personalized health and wellness solutions through scientifically backed formulations and cutting-edge biotechnological advancements.
Kangweijian Bio — Kangweijian Bio is a health food manufacturer and distributor dedicated to delivering safe, high-quality products and services across global markets, specializing in food and cosmetic raw materials, health food ingredients, pharmaceutical excipients, and animal nutrition.
Rongrui Technology — Rongrui Technology is an industrial enzyme developer, involved in industrial enzyme research and development; technical services, technology development, technology consulting, technology exchange, technology transfer, and technology promotion.

Investors by industry

Community

Artificial intelligence